A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
Phase 2 Completed
47 enrolled 8 charts
A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)
Phase 2 Completed
192 enrolled 22 charts
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
Phase 2 Completed
51 enrolled
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Phase 2 Completed
43 enrolled 9 charts
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Phase 2 Completed
78 enrolled 13 charts
Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Phase 2 Completed
51 enrolled 19 charts
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
Phase 2 Completed
43 enrolled 10 charts
2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
Phase 2 Completed
10 enrolled
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
Phase 2 Completed
78 enrolled 16 charts
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders
Phase 2 Completed
5 enrolled
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Phase 2 Completed
99 enrolled 13 charts
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Phase 2 Completed
25 enrolled 9 charts
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
Phase 2 Completed
41 enrolled 13 charts
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Phase 2 Completed
196 enrolled 26 charts
CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies
Phase 2 Completed
14 enrolled
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
Phase 2 Completed
30 enrolled
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Phase 2 Completed
81 enrolled
JAKARTA2
Phase 2 Completed
97 enrolled
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Phase 2 Completed
61 enrolled 10 charts
Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
Phase 2 Completed
22 enrolled 15 charts
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
Phase 2 Completed
100 enrolled 38 charts
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
Phase 2 Completed
19 enrolled 18 charts
Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
Phase 2 Completed
38 enrolled
UK-Haplo
Phase 2 Completed
77 enrolled
FEMITGIGVHD
Phase 2 Completed
6 enrolled
Vaccine Therapy in Treating Patients With Multiple Myeloma
Phase 2 Completed
Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk
Phase 2 Completed
37 enrolled 6 charts
A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)
Phase 2 Completed
19 enrolled 11 charts
CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia
Phase 2 Completed
18 enrolled
TTRAP-Bleeding
Phase 2 Completed
18 enrolled
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings
Phase 2 Completed
107 enrolled 24 charts
Pasireotide in Prevention of GI Toxicity
Phase 2 Completed
37 enrolled 15 charts
Nonmyeloablative Haploidentical Transplant Followed by MLN9708
Phase 2 Completed
29 enrolled 14 charts
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
Phase 2 Completed
303 enrolled 15 charts
Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)
Phase 2 Completed
52 enrolled 10 charts
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Phase 2 Completed
15 enrolled 15 charts
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Phase 2 Completed
31 enrolled 12 charts
Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)
Phase 2 Completed
47 enrolled 10 charts
IBCB
Phase 2 Completed
23 enrolled
SIGNATURE
Phase 2 Completed
110 enrolled 18 charts
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
Phase 2 Completed
58 enrolled 11 charts
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Phase 2 Completed
140 enrolled
Phase II Maraviroc for GVHD Prevention
Phase 2 Completed
37 enrolled 17 charts
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Phase 2 Completed
176 enrolled 18 charts
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
Phase 2 Completed
6 enrolled 5 charts
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Phase 2 Completed
55 enrolled 11 charts
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
Phase 2 Completed
77 enrolled 10 charts
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
Phase 2 Completed
40 enrolled 11 charts
ALBUM
Phase 2 Completed
16 enrolled 7 charts
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Phase 2 Completed
16 enrolled 11 charts